OCULAR THERAPEUTIX, INC - Common Stock, $0.0001 par value per share (OCUL)

Q: What does CUSIP 67576A100 represent in this 13F holders report?

CUSIP 67576A100 is the security identifier for OCUL - OCULAR THERAPEUTIX, INC - Common Stock, $0.0001 par value per share used to aggregate holder disclosures.

Q: How many institutions held OCUL - OCULAR THERAPEUTIX, INC - Common Stock, $0.0001 par value per share in Q2 2016?

74 institutional investors reported OCUL - OCULAR THERAPEUTIX, INC - Common Stock, $0.0001 par value per share for Q2 2016. Use the holders table for investor-level position and value details.

CUSIP: 67576A100

Q2 2016 13F Holders as of 30 Jun 2016

Type / Class: Equity / Common Stock, $0.0001 par value per share
Shares outstanding: 218,782,791
Total 13F shares: 19,471,110
Share change: -1,390,139
Total reported value: $96,376,641
Put/Call ratio: 50%
Price per share: $4.95
Number of holders: 74
Value change: -$30,443,305
Number of buys: 50
Number of sells: 19

Quarterly Holders Quick Answers

What is CUSIP 67576A100?
CUSIP 67576A100 identifies OCUL - OCULAR THERAPEUTIX, INC - Common Stock, $0.0001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2016
Previous quarter: Q1 2016

Recent filing periods for CUSIP 67576A100:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of OCUL - OCULAR THERAPEUTIX, INC - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
FMR LLC	13F	Company	1.5%	3,179,557	$30,715,000	—	31 Mar 2016	13F
Capital Research Global Investors	13F	Company	1.3%	2,865,358	$27,679,000	—	31 Mar 2016	13F
Versant Venture Management, LLC	13F	Company	1%	2,215,384	$21,400,609	—	31 Mar 2016	13F
Capital World Investors	13F	Company	0.93%	2,028,000	$19,590,000	—	31 Mar 2016	13F
SV Health Investors, LLC	13F	Company	0.88%	1,932,607	$18,669,000	—	31 Mar 2016	13F
FEDERATED HERMES, INC.	13F	Company	0.75%	1,647,233	$15,912,000	—	31 Mar 2016	13F
JENNISON ASSOCIATES LLC	13F	Company	0.61%	1,329,345	$12,841,000	—	31 Mar 2016	13F
Polaris Venture Management Co. V, L.L.C.	13F	Company	0.56%	1,230,009	$11,882,000	—	31 Mar 2016	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	0.4%	864,768	$8,353,000	—	31 Mar 2016	13F
BlackRock Fund Advisors	13F	Company	0.32%	703,729	$6,798,000	—	31 Mar 2016	13F
VANGUARD GROUP INC	13F	Company	0.21%	455,516	$4,400,000	—	31 Mar 2016	13F
BlackRock Institutional Trust Company, N.A.	13F	Company	0.12%	261,860	$2,530,000	—	31 Mar 2016	13F
BAILARD, INC.	13F	Company	0.1%	219,752	$2,123,000	—	31 Mar 2016	13F
STATE STREET CORP	13F	Company	0.09%	205,586	$1,989,000	—	31 Mar 2016	13F
COLUMBUS CIRCLE INVESTORS	13F	Company	0.09%	188,502	$1,821,000	—	31 Mar 2016	13F
NOTTINGHAM ADVISORS, INC.	13F	Company	0.08%	182,266	$1,708,000	—	31 Mar 2016	13F
NORTHERN TRUST CORP	13F	Company	0.07%	163,049	$1,575,000	—	31 Mar 2016	13F
COWEN INC.	13F	Company	0.07%	145,700	$1,407,000	—	31 Mar 2016	13F
DEUTSCHE BANK AG\	13F	Company	0.05%	99,629	$961,000	—	31 Mar 2016	13F
D. E. Shaw & Co., Inc.	13F	Company	0.04%	89,730	$867,000	—	31 Mar 2016	13F
BALYASNY ASSET MANAGEMENT L.P.	13F	Company	0.04%	85,000	$821,000	—	31 Mar 2016	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.03%	70,396	$680,000	—	31 Mar 2016	13F
Bank of New York Mellon Corp	13F	Company	0.03%	60,747	$586,000	—	31 Mar 2016	13F
BlackRock Investment Management, LLC	13F	Company	0.02%	53,813	$520,000	—	31 Mar 2016	13F
TIAA CREF INVESTMENT MANAGEMENT LLC	13F	Company	0.02%	48,468	$468,000	—	31 Mar 2016	13F
EDMOND DE ROTHSCHILD (SUISSE) S.A.	13F	Company	0.02%	45,000	$435,000	—	31 Mar 2016	13F
EDMOND DE ROTHSCHILD HOLDING S.A.	13F	Company	0.02%	45,000	$435,000	—	31 Mar 2016	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.02%	44,353	$429,000	—	31 Mar 2016	13F
Rhenman & Partners Asset Management AB	13F	Company	0.02%	40,000	$386,000	—	31 Mar 2016	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.01%	32,450	$313,000	—	31 Mar 2016	13F
Polar Capital LLP	13F	Company	0.01%	30,000	$290,000	—	31 Mar 2016	13F
ALPS ADVISORS INC	13F	Company	0.01%	27,816	$269,000	—	31 Mar 2016	13F
MORGAN STANLEY	13F	Company	0.01%	22,822	$220,000	—	31 Mar 2016	13F
TEACHERS ADVISORS, LLC	13F	Company	0.01%	21,432	$207,000	—	31 Mar 2016	13F
ProShare Advisors LLC	13F	Company	0.01%	20,009	$193,000	—	31 Mar 2016	13F
Veritable, L.P.	13F	Company	0.01%	20,000	$193,000	—	31 Mar 2016	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.01%	18,570	$180,000	—	31 Mar 2016	13F
Swiss National Bank	13F	Company	0.01%	16,800	$156,000	—	31 Mar 2016	13F
CANADA LIFE ASSURANCE Co	13F	Company	0.01%	16,146	$155,000	—	31 Mar 2016	13F
RHUMBLINE ADVISERS	13F	Company	0.01%	14,954	$144,000	—	31 Mar 2016	13F
BlackRock Group LTD	13F	Company	0.01%	13,142	$127,000	—	31 Mar 2016	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.01%	12,800	$124,000	—	31 Mar 2016	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.01%	12,000	$116,000	—	31 Mar 2016	13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE	13F	Company	0.01%	11,183	$105,000	—	31 Mar 2016	13F
CITIGROUP INC	13F	Company	0%	10,522	$102,000	—	31 Mar 2016	13F
Deutsche Girozentrale DekaBank	13F	Individual	0%	10,000	$94,000	—	31 Mar 2016	13F
Nationwide Fund Advisors	13F	Company	0%	9,608	$93,000	—	31 Mar 2016	13F
AMERICAN INTERNATIONAL GROUP, INC.	13F	Company	0%	7,632	$74,000	—	31 Mar 2016	13F
PURA VIDA INVESTMENTS, LLC	13F	Company	0%	6,000	$58,000	—	31 Mar 2016	13F
BLACKROCK ADVISORS LLC	13F	Company	0%	5,119	$49,000	—	31 Mar 2016	13F

Institutional Holders of OCULAR THERAPEUTIX, INC - Common Stock, $0.0001 par value per share (OCUL) as of Q2 2016

As of 30 Jun 2016, OCULAR THERAPEUTIX, INC - Common Stock, $0.0001 par value per share (OCUL) was held by 74 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 19,471,110 shares. The largest 10 holders included FMR LLC, JENNISON ASSOCIATES LLC, Versant Venture Management, LLC, SV Life Sciences Advisers, LLC, FEDERATED INVESTORS INC /PA/, Polaris Venture Management Co. V, L.L.C., WELLINGTON MANAGEMENT GROUP LLP, BlackRock Fund Advisors, VANGUARD GROUP INC, and PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C.. This page lists 74 institutional shareholders reporting positions in this security for the Q2 2016 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2016 vs Q1 2016 Across Filers

Q1 2016 holders

Q2 2016 holders

Holder diff

Investor	Q1 2016 Shares	Q2 2016 Shares	Share Diff	Share Chg %	Q1 2016 Value $	Q2 2016 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.